What’s driving the non-muscle-invasive bladder cancer market? | Healthcare Asia Magazine
, APAC
Photo by Los Muertos Crew via Pexels

What’s driving the non-muscle-invasive bladder cancer market?

It is driven by a surge in NMIBC cases.

The market for non-muscle-invasive bladder cancer (NMIBC) is anticipated to grow significantly, reaching $2.6b in 2023, with a compound annual growth rate (CAGR) of 15% projected through 2034. 

The growth is driven by a surge in NMIBC cases, now nearing 1.5 million in the seven major markets (7MM), particularly amongst intermediate-risk patients.

High-risk NMIBC is predicted to account for the largest market share, estimated at approximately $1.6b.

Current treatment options include surgery, intravesical immunotherapy (BCG), and chemotherapy. For intermediate and high-risk patients, the standard approach involves Transurethral Resection of Bladder Tumor (TURBT) followed by BCG immunotherapy. Regular monitoring through cystoscopy is recommended every three to six months.

The FDA has approved three key drugs for NMIBC, including KEYTRUDA ADSTILADRIN, and ANKTIVA. 

A persistent BCG shortage, exacerbated by the COVID-19 pandemic, has led healthcare providers to seek alternative treatments such as gemcitabine and docetaxel. Efforts are underway to address the BCG supply issue through strategic partnerships.

Emerging therapies are also on the horizon, including Johnson & Johnson’s TAR-200 and CG Oncology’s CG0070, the latter of which is currently in Phase III trials and shows potential when combined with checkpoint inhibitors.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!